Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Haemophilia A: full-pipeline trial registry
3 of 9 indexed Haemophilia A trials are currently recruiting.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 3 currently recruiting · #1,916 of 28,707 conditions by registered trial count
Haemophilia A: 9 US clinical trials tracked, 3 recruiting.
Haemophilia A is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Novo Nordisk A/S, running 8 of these trials.
Enrollment posture brief
Registry condition haemophilia-a
OPEN 3 | RECR 33% | LATE 4 | EARLY 3 | RANK #1916 | SPON 8
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Haemophilia A lists 3 open slots (33% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Haemophilia A on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Haemophilia A is recruiting below its size-band peers.
3 of 9 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Haemophilia A research.
Novo Nordisk A/S accounts for 8 of 9 trials (88.9%). 2 distinct sponsors appear on at least one study for this condition label.
-
Typical Haemophilia A enrolment sits around 186 participants.
Median target enrolment is 186 among the 9 trials that report a genuine target (sentinel values excluded). 4 of those (44.4%) plan for fewer than 100 participants.
-
Haemophilia A research is mostly interventional.
7 interventional and 2 observational studies make up this index (77.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
Octapharma
NCT03695978
A Research Study Looking at How Food Intake Affects Inno8 in the Body of Healthy People
Novo Nordisk A/S
NCT07238816
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Novo Nordisk A/S
NCT07220564
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A (FRONTIER 4)
Novo Nordisk A/S
NCT05685238
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Novo Nordisk A/S
NCT03660774
Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015
Novo Nordisk A/S
NCT00984126
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Novo Nordisk A/S
NCT01480180
Safety and Efficacy of Turoctocog Alfa in Previously Treated Male Children With Haemophilia A
Novo Nordisk A/S
NCT01138501
Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of Concizumab Administered Subcutaneously to Haemophilia A Subjects
Novo Nordisk A/S
NCT02490787
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 3 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Haemophilia A records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Haemophilia A trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Haemophilia A page
9 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Haemophilia A trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Novo Nordisk A/S sponsors the most Haemophilia A trials on record, review their full trial history before evaluating a specific study. See Novo Nordisk A/S's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Haemophilia A condition card totals 9 registered trials; most-linked intervention turoctocog alfa; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.